Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Clinical trial NCT06733987 · RECRUITING
Trial details
- NCT number
- NCT06733987
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-01
- Primary completion
- 2027-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.